Evidence map›Paper›PMID 40354427›Full record

ArticlePloS one2025

Infectious potential and circulation of SARS-CoV-2 in wild rats.

Kevyn Beissat, Virginie Lattard, Evelyne Picard-Meyer, Ambre Fafournoux, Sionfoungo Daouda Soro, Alexandre Servat, Françoise Vincent-Hubert, Franck Boué, Nolan Chatron, Elodie Monchâtre-Leroy and 1 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kevyn BeissatNancy Laboratory for Rabies and Wildlife, ANSES, Malzéville, Nancy, France.
Virginie LattardUSC-1233 Rongeurs Sauvages Risques Sanitaires et Gestion des Populations (RS2GP), VetAgroSup, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Lyon University, Marcy-L'Etoile, France.
Evelyne Picard-MeyerNancy Laboratory for Rabies and Wildlife, ANSES, Malzéville, Nancy, France.
Ambre FafournouxUSC-1233 Rongeurs Sauvages Risques Sanitaires et Gestion des Populations (RS2GP), VetAgroSup, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Lyon University, Marcy-L'Etoile, France.
Sionfoungo Daouda SoroUSC-1233 Rongeurs Sauvages Risques Sanitaires et Gestion des Populations (RS2GP), VetAgroSup, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Lyon University, Marcy-L'Etoile, France.
Alexandre ServatNancy Laboratory for Rabies and Wildlife, ANSES, Malzéville, Nancy, France.
Françoise Vincent-HubertIFREMER, Laboratoire Santé, Environnement et Microbiologie (LSEM) - MASAE, rue de l'île d'Yeu, , Nantes, France/ Groupement d'intérêt scientifique (GIS) Obépine, https://www.reseau-obepine.fr.
Franck BouéNancy Laboratory for Rabies and Wildlife, ANSES, Malzéville, Nancy, France.
Nolan ChatronUSC-1233 Rongeurs Sauvages Risques Sanitaires et Gestion des Populations (RS2GP), VetAgroSup, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Lyon University, Marcy-L'Etoile, France.
Elodie Monchâtre-LeroyNancy Laboratory for Rabies and Wildlife, ANSES, Malzéville, Nancy, France.
Marine WasniewskiNancy Laboratory for Rabies and Wildlife, ANSES, Malzéville, Nancy, France.ORCID https://orcid.org/0000-0001-5054-3634

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, a wide range of animal species (pets, mink…) have been naturally infected with this betacoronavirus. The emergence of new variants has increased the ability of SARS-CoV-2 to infect species that were not susceptible to the "original" SARS-CoV-2, such as mice and rats. This work attempted to evaluate the role of urban rats in the SARS-CoV-2 transmission by combining surveillance studies of rat populations in urban environments, in vivo experimental inoculation of SARS-CoV-2 and comparative viral-receptor interaction in silico analyses. We studied the circulation of SARS-CoV-2 in wild Rattus norvegicus (n = 401) captured in urban areas and sewage systems of several French cities. Except for 3 inconclusive samples (2/75 from Bordeaux and 1/261 from Lyon) none of the 353 sera tested showed anti-SARS-CoV-2 antibodies by microsphere immunoassay. However, the 3 inconclusive sera samples were negative by virus neutralisation assay. No SARS-CoV-2 viral RNA was detected in all lungs collected from the 401 captured urban brown rats. In complement, four rat groups (two wild-type colonies, Rattus norvegicus and Rattus rattus, and two laboratory strains, Sprague-Dawley and Wistar) were inoculated with the SARS-CoV-2 Omicron BA.5. At 4 days post-inoculation, no infectious viral particles were detected in the lungs and upper respiratory tract (URT) while viral RNA was detected at a low level only in the URT of all groups. In addition, seroconversion was observed 14 days after inoculation in the four groups. By molecular modelling, the Omicron BA.5 receptor binding domain (RBD) had lower affinities for Rattus norvegicus and Rattus rattus ACE2 than Homo sapiens ACE2. Based on these results the SARS-CoV-2 Omicron BA.5 was unable to infect laboratory and wild type rats. In addition, Rattus norvegicus collected for this study in different areas of France were not infected with SARS-CoV-2.

Indexed as

Angiotensin-Converting Enzyme 2AnimalsAnimals, WildAntibodies, ViralCOVID-19FranceHumansPandemicsRatsRNA, ViralSARS-CoV-2Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Antibodies, ViralRNA, ViralSpike Glycoprotein, Coronavirus

Identifiers

PMID40354427
PMCPMC12068656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.